Risk of Barrett's Oesophagus with Bulimia
Patients with bulimia nervosa who engage in frequent self-induced vomiting are at theoretical increased risk for Barrett's oesophagus due to chronic acid exposure, though the actual magnitude of this risk remains poorly quantified and likely lower than initially feared.
Understanding the Pathophysiologic Link
The connection between bulimia and Barrett's oesophagus stems from the established risk factors for Barrett's. The main risk factors for Barrett's oesophagus are a history of gastro-oesophageal acid reflux symptoms and obesity 1. Self-induced vomiting in bulimia nervosa creates repeated acid exposure to the oesophageal mucosa, theoretically mimicking chronic gastroesophageal reflux disease (GERD).
Barrett's oesophagus develops when squamous epithelium in the distal esophagus is replaced by metaplastic specialized columnar epithelium in response to chronic gastroesophageal reflux-induced injury and inflammation 2. This is the only identifiable precursor lesion for esophageal adenocarcinoma, which has a dismal 5-year survival rate of approximately 20% 2.
Evidence Quality and Limitations
The evidence linking bulimia specifically to Barrett's oesophagus is limited to case reports and small observational studies with significant methodological weaknesses 3. A comprehensive literature review found several case reports of esophageal tumors in patients with bulimia history, and studies showing higher incidences of reflux symptoms in eating disordered patients compared to controls, but noted "large variability in study design, quality and results" 3. The association is suggested as possible but is far from being proved conclusively 3.
Importantly, an endoscopic study of 37 consecutive patients with long-standing bulimia nervosa found that mucosal injury consequent to chronic, self-induced vomiting was relatively infrequent and limited 4. The esophageal and gastric mucosa appeared normal in 23 patients, with only mild esophagitis in 8 patients, and no erosions, ulcers, or bleeding observed 4.
Clinical Implications for Bulimic Patients
Who Warrants Concern:
- Patients with prolonged duration of purging behaviors (typically years to decades)
- Those with concurrent GERD symptoms beyond vomiting episodes
- Patients with additional risk factors: male sex, smoking, obesity, family history of Barrett's or esophageal adenocarcinoma 1
- Those with anorexia nervosa binge-purge subtype (ANBP), who are behaviorally similar to bulimia nervosa patients 5
Red Flag Symptoms:
- Persistent dysphagia (difficulty swallowing)
- Progressive weight loss beyond intentional purging effects
- Chronic heartburn or regurgitation independent of purging episodes
- Hematemesis or signs of gastrointestinal bleeding
Management Approach
For bulimic patients with chronic reflux symptoms or prolonged purging history:
Aggressive acid suppression with daily proton pump inhibitor (PPI) therapy is conditionally recommended to prevent progression in Barrett's oesophagus 2, and would be appropriate for symptomatic bulimic patients
Consider endoscopic evaluation in patients with:
- Persistent reflux symptoms despite PPI therapy
- Duration of purging behaviors exceeding 10-15 years
- Development of alarm symptoms (dysphagia, bleeding, weight loss beyond expected)
- Multiple additional risk factors for Barrett's
Prioritize cessation of vomiting behavior, as this is necessary to cure most associated medical complications 6
If Barrett's is diagnosed, follow standard surveillance protocols:
- For Barrett's ≥1 cm and <3 cm: surveillance every 5 years
- For Barrett's ≥3 cm and <10 cm: surveillance every 3 years
- For Barrett's ≥10 cm: refer to Barrett's expert center 7
Critical Caveats
The actual risk magnitude remains uncertain. While case reports exist demonstrating Barrett's and even esophageal adenocarcinoma in bulimic patients 3, 5, population-based risk estimates are lacking. The endoscopic findings in systematic evaluation of bulimic patients suggest the risk may be lower than theoretical concerns would suggest 4.
Medical complications of self-induced vomiting affect nearly every organ system 6, 8, so the focus should remain on comprehensive eating disorder treatment rather than isolated concern about Barrett's oesophagus.
Dysplasia and early cancer usually develop without clinical signs, often in individuals whose symptoms are well controlled by acid suppressant medications 1, making it impossible to rely on symptoms alone for risk stratification in this population.